Fundraising Fox

Andrew Conrad

Investor

General Partner at S32

About

General Partner of S32 and founder and former CEO/Executive Chairman of Verily, Alphabet's healthcare company. Previously CSO of LabCorp and co-founder of the National Genetics Institute; holds a PhD in cell biology from UCLA.

Contact· self-published, not guessed

Deals · 2

MedCryptBoard seat

via S32 · filed Feb 2025 · $8.7M raise

Alpha SourceBoard seat

via S32 · filed Nov 2022 · $25.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at S32

Ainhoa Maiz
Principal at S32
Alice Cheung
Partner, Talent at S32
Allison Pavlick
Investor Relations Principal at S32
Andy Harrison
General Partner, CEO at S32
Ayesha Arora
Venture Partner at S32
Bayan Alizadeh
Partner at S32
Bill Maris
General Partner, Founder at S32
Carlos Solórzano
Principal at S32

Frequently asked questions

Who is Andrew Conrad?
General Partner of S32 and founder and former CEO/Executive Chairman of Verily, Alphabet's healthcare company. Previously CSO of LabCorp and co-founder of the National Genetics Institute; holds a PhD in cell biology from UCLA.
Where does Andrew Conrad work?
Andrew Conrad is General Partner at S32.
What boards does Andrew Conrad sit on?
Andrew Conrad holds tracked board seats at Alpha Source, MedCrypt.